These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 19335705

  • 21. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
    Nakamura K, Schwartz BS, Lindegårdh N, Keh C, Guglielmo BJ.
    Clin Infect Dis; 2010 Apr 01; 50(7):e47-9. PubMed ID: 20192728
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.
    Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F.
    Arch Intern Med; 2003 Jul 28; 163(14):1667-72. PubMed ID: 12885681
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
    Sugaya N, Tamura D, Yamazaki M, Ichikawa M, Kawakami C, Kawaoka Y, Mitamura K.
    Clin Infect Dis; 2008 Aug 01; 47(3):339-45. PubMed ID: 18582202
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons.
    Kawai N, Ikematsu H, Iwaki N, Maeda T, Satoh I, Hirotsu N, Kashiwagi S.
    Clin Infect Dis; 2006 Aug 15; 43(4):439-44. PubMed ID: 16838232
    [Abstract] [Full Text] [Related]

  • 31. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.
    Kawai N, Ikematsu H, Iwaki N, Kondou K, Hirotsu N, Kawashima T, Maeda T, Tanaka O, Doniwa K, Kashiwagi S.
    J Infect; 2009 Sep 15; 59(3):207-12. PubMed ID: 19619898
    [Abstract] [Full Text] [Related]

  • 32. Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry.
    Adisasmito W, Chan PK, Lee N, Oner AF, Gasimov V, Aghayev F, Zaman M, Bamgboye E, Dogan N, Coker R, Starzyk K, Dreyer NA, Toovey S.
    J Infect Dis; 2010 Oct 15; 202(8):1154-60. PubMed ID: 20831384
    [Abstract] [Full Text] [Related]

  • 33. Oseltamivir for treatment of influenza in infants less than one year: a retrospective analysis.
    Siedler K, Skopnik H.
    Pediatr Infect Dis J; 2010 Jun 15; 29(6):495-8. PubMed ID: 20035245
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Association between oseltamivir use and neuropsychiatric adverse events in influenza patients: a nationwide population-based cohort study.
    Kang HR, Jang SC, Shin JY.
    Expert Opin Drug Saf; 2021 Feb 15; 20(2):245-253. PubMed ID: 33183123
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The course of fever following influenza virus infection in children treated with oseltamivir.
    Suzuki E, Ichihara K.
    J Med Virol; 2008 Jun 15; 80(6):1065-71. PubMed ID: 18428131
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.